Literature DB >> 20180238

Effects of anti-hypertensive drugs on esophageal body contraction.

Koichi Yoshida1, Kenji Furuta, Kyoichi Adachi, Shunji Ohara, Terumi Morita, Takashi Tanimura, Shuji Nakata, Masaharu Miki, Kenji Koshino, Yoshikazu Kinoshita.   

Abstract

AIM: To clarify the effects of anti-hypertensive drugs on esophageal contraction and determine their possible relationship with gastro-esophageal reflux disease.
METHODS: Thirteen healthy male volunteers were enrolled. Esophageal body peristaltic contractions and lower esophageal sphincter (LES) pressure were measured using high resolution manometry. All subjects were randomly examined on four separate occasions following administrations of nifedipine, losartan, and atenolol, as well as without any drug administration.
RESULTS: Peristaltic contractions by the esophageal body were separated into three segments by two troughs. The peak peristaltic pressures in the mid and lower segments of the esophageal body under atenolol administration were significantly higher than those without medication in a supine position. On the other hand, peristaltic pressures under nifedipine administration were lower than those observed without drug administration. Losartan did not change esophageal body peristalsis. Atenolol elevated LES pressure and slowed peristaltic wave transition, while the effects of nifedipine were the opposite.
CONCLUSION: Among the anti-hypertensive drugs tested, atenolol enhanced esophageal motor activity, which was in contrast to nifedipine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20180238      PMCID: PMC2828604          DOI: 10.3748/wjg.v16.i8.987

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  22 in total

1.  Effect of nifedipine administration (10 mg) on esophageal acid exposure time.

Authors:  H Ishikawa; K Iwakiri; T Sugiura; M Kobayashi
Journal:  J Gastroenterol       Date:  2000       Impact factor: 7.527

2.  Application of topographical methods to clinical esophageal manometry.

Authors:  R E Clouse; A Staiano; A Alrakawi; L Haroian
Journal:  Am J Gastroenterol       Date:  2000-10       Impact factor: 10.864

Review 3.  Topographic esophageal manometry: an emerging clinical and investigative approach.

Authors:  R E Clouse; C Prakash
Journal:  Dig Dis       Date:  2000       Impact factor: 2.404

4.  Effects of position on oesophageal function: studies using combined manometry and multichannel intraluminal impedance.

Authors:  R Tutuian; J P Elton; D O Castell; R Matthew Gideon; J A Castell; P O Katz
Journal:  Neurogastroenterol Motil       Date:  2003-02       Impact factor: 3.598

Review 5.  Components of the standard oesophageal manometry.

Authors:  J A Murray; R E Clouse; J L Conklin
Journal:  Neurogastroenterol Motil       Date:  2003-12       Impact factor: 3.598

6.  Topography of the esophageal peristaltic pressure wave.

Authors:  R E Clouse; A Staiano
Journal:  Am J Physiol       Date:  1991-10

Review 7.  Current trends in the management of achalasia.

Authors:  S Bruley des Varannes; C Scarpignato
Journal:  Dig Liver Dis       Date:  2001-04       Impact factor: 4.088

8.  Intramural mechanism of esophageal peristalsis: roles of cholinergic and noncholinergic nerves.

Authors:  J Crist; J S Gidda; R K Goyal
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Increased risk of exacerbating gastrointestinal disease among elderly patients following treatment with calcium channel blockers.

Authors:  A Hamada; J Ishii; K Doi; N Hamada; C Miyazaki; T Hamada; Y Ohwaki; M Wada; K Nakashima
Journal:  J Clin Pharm Ther       Date:  2008-12       Impact factor: 2.512

10.  Failure of esophageal peristalsis in older patients: association with esophageal acid exposure.

Authors:  A Cristina Achem; Sami R Achem; Mark E Stark; Kenneth R DeVault
Journal:  Am J Gastroenterol       Date:  2003-01       Impact factor: 10.864

View more
  7 in total

1.  Effects of mosapride on esophageal motor activity and esophagogastric junction compliance in healthy volunteers.

Authors:  Kousuke Fukazawa; Kenji Furuta; Kyoichi Adachi; Yoshiya Moritou; Tsukasa Saito; Ryusaku Kusunoki; Goichi Uno; Shino Shimura; Masahito Aimi; Shunji Ohara; Shunji Ishihara; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2013-09-07       Impact factor: 7.527

2.  Association between metabolic syndrome and prevalence of gastroesophageal reflux disease in a health screening facility in Japan.

Authors:  Masatoshi Niigaki; Kyoichi Adachi; Kazuya Hirakawa; Kenji Furuta; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2012-09-14       Impact factor: 7.527

3.  Calcium channel blockers and esophageal sclerosis: should we expect exacerbation of interstitial lung disease?

Authors:  Charalampos Seretis; Fotios Seretis; George Gemenetzis; Nikolaos Liakos; Apostolos Pappas; Stavros Gourgiotis; Emmanuel Lagoudianakis; Dimitrios Keramidaris; Nikolaos Salemis
Journal:  Case Rep Gastroenterol       Date:  2012-01-31

4.  Effects of Rikkunshito (TJ-43) on Esophageal Motor Function and Gastroesophageal Reflux.

Authors:  Terumi Morita; Kenji Furuta; Kyoichi Adachi; Shunji Ohara; Takashi Tanimura; Kenji Koshino; Tomochika Uemura; Kohji Naora; Yoshikazu Kinoshita
Journal:  J Neurogastroenterol Motil       Date:  2012-04-09       Impact factor: 4.924

5.  Influence of Full-body Water Immersion on Esophageal Motor Function and Intragastric Pressure.

Authors:  Masahito Aimi; Kenji Furuta; Tsukasa Saito; Shino Shimura; Kousuke Fukazawa; Shunji Ohara; Goichi Uno; Hiroshi Tobita; Kyoichi Adachi; Yoshikazu Kinoshita
Journal:  J Neurogastroenterol Motil       Date:  2012-04-09       Impact factor: 4.924

6.  Association of medications for lifestyle-related diseases with reflux esophagitis.

Authors:  Daisuke Asaoka; Akihito Nagahara; Mariko Hojo; Kenshi Matsumoto; Hiroya Ueyama; Kohei Matsumoto; Kentaro Izumi; Tsutomu Takeda; Hiroyuki Komori; Yoichi Akazawa; Yuji Shimada; Taro Osada; Sumio Watanabe
Journal:  Ther Clin Risk Manag       Date:  2016-10-04       Impact factor: 2.423

7.  Gender, medication use and other factors associated with esophageal motility disorders in non-obstructive dysphagia.

Authors:  Afrin Kamal; Sampurna Shakya; Rocio Lopez; Prashanthi N Thota
Journal:  Gastroenterol Rep (Oxf)       Date:  2018-06-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.